Balyasny Asset Management LLC Neuronetics, Inc. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,144,232 shares of STIM stock, worth $720,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,144,232
Previous 1,144,232
-0.0%
Holding current value
$720,866
Previous $2.06 Million
57.8%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding STIM
# of Institutions
50Shares Held
13.1MCall Options Held
30.1KPut Options Held
0-
Kent Lake Pr LLC Anasco, PR2.08MShares$1.31 Million0.63% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$1.1 Million1.44% of portfolio
-
Cannell Capital LLC Alta, WY1.31MShares$827,9870.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$818,9460.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.2MShares$756,0000.05% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $17M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...